Universal screening for the SARS-CoV-2 virus on hospital admission in an area with low COVID-19 prevalence.
作者信息
Sastry Sangeeta R, Pryor Rachel, Raybould Jillian E, Reznicek Julie, Cooper Kaila, Patrick Amie, Knowlson Shelley, Bailey Pamela, Godbout Emily, Doll Michelle, Stevens Michael P, Bearman Gonzalo
机构信息
Division of Infectious Diseases, Virginia Commonwealth University, Richmond, Virginia.
出版信息
Infect Control Hosp Epidemiol. 2020 Oct;41(10):1231-1233. doi: 10.1017/ice.2020.358. Epub 2020 Jul 23.
Abstract
摘要
相似文献
1
Universal screening for the SARS-CoV-2 virus on hospital admission in an area with low COVID-19 prevalence.
Infect Control Hosp Epidemiol. 2020 Oct;41(10):1231-1233. doi: 10.1017/ice.2020.358. Epub 2020 Jul 23.
2
Universal SARS-CoV-2 testing on admission to the labor and delivery unit: Low prevalence among asymptomatic obstetric patients.
Infect Control Hosp Epidemiol. 2020 Sep;41(9):1095-1096. doi: 10.1017/ice.2020.255. Epub 2020 May 27.
3
Outcomes of universal SARS-CoV-2 testing program in pregnant women admitted to hospital and the adjuvant role of lung ultrasound in screening: a prospective cohort study.
J Matern Fetal Neonatal Med. 2020 Nov;33(22):3820-3826. doi: 10.1080/14767058.2020.1798398. Epub 2020 Jul 28.
4
Parental Coronavirus Disease 2019 Testing of Hospitalized Children: Rethinking Infection Control in a Pandemic.
J Pediatric Infect Dis Soc. 2020 Nov 10;9(5):564-565. doi: 10.1093/jpids/piaa103.
5
Biphasic Variation Over Time in Presenting Features of Patients With COVID-19.
Pediatrics. 2020 Nov;146(5). doi: 10.1542/peds.2020-014902. Epub 2020 Sep 3.
6
Universal screening for SARS-CoV-2 before labor admission during Covid-19 pandemic in Madrid.
J Perinat Med. 2020 Nov 26;48(9):981-984. doi: 10.1515/jpm-2020-0236.
7
Universal SARS-Cov-2 Screening in Women Admitted for Delivery in a Large Managed Care Organization.
Am J Perinatol. 2020 Sep;37(11):1110-1114. doi: 10.1055/s-0040-1714060. Epub 2020 Jul 3.
8
Screening maternity populations during the COVID-19 pandemic.
BJOG. 2020 Nov;127(12):1557. doi: 10.1111/1471-0528.16439. Epub 2020 Sep 1.
9
COVID-19 in pregnancy in South Africa: Tracking the epidemic and defining the natural history.
S Afr Med J. 2020 Jul 30;110(8):729-731. doi: 10.7196/SAMJ.2020.v110i8.15012.
10
Multicenter Evaluation of the Cepheid Xpert Xpress SARS-CoV-2 Assay for the Detection of SARS-CoV-2 in Oropharyngeal Swab Specimens.
J Clin Microbiol. 2020 Jul 23;58(8). doi: 10.1128/JCM.01288-20.
引用本文的文献
1
Coronavirus disease 2019 (COVID-19) universal admission screening in patients and companions in Taiwan from May 2021 to June 2022: A nationwide multicenter study.
Infect Control Hosp Epidemiol. 2024 Jan;45(1):68-74. doi: 10.1017/ice.2023.144. Epub 2023 Jul 18.
2
COVID-19 patient and personal safety - lessons learnt for pandemic preparedness and the way to the next normal.
Antimicrob Resist Infect Control. 2023 Apr 1;12(1):27. doi: 10.1186/s13756-023-01231-1.
3
The impact of caregivers on nosocomial transmission during a COVID-19 outbreak in a community-based hospital in South Korea.
PLoS One. 2022 Nov 21;17(11):e0277816. doi: 10.1371/journal.pone.0277816. eCollection 2022.
4
Preadmission testing for COVID-19 as a screening strategy: a retrospective chart review from a tertiary hospital in Kenya.
Infect Prev Pract. 2022 Sep;4(3):100231. doi: 10.1016/j.infpip.2022.100231. Epub 2022 Jul 4.
5
Clinical characteristics of patients with asymptomatic and symptomatic COVID-19 admitted to a tertiary referral centre in the Philippines.
IJID Reg. 2022 Mar;2:204-211. doi: 10.1016/j.ijregi.2022.02.002. Epub 2022 Feb 6.
6
Provision of safe patient care during the COVID-19 pandemic despite shared patient rooms in a tertiary hospital.
Antimicrob Resist Infect Control. 2022 Apr 21;11(1):61. doi: 10.1186/s13756-022-01091-1.
7
A Large-Scale Screening Responding Sporadic Epidemic of COVID-19 in China by an Integrated Health-Care System.
Int J Integr Care. 2022 Mar 23;22(1):23. doi: 10.5334/ijic.5941. eCollection 2022 Jan-Mar.
8
SARS-CoV-2 testing in patients with low COVID-19 suspicion at admission to a tertiary care hospital, Stockholm, Sweden, March to September 2020.
Euro Surveill. 2022 Feb;27(7). doi: 10.2807/1560-7917.ES.2022.27.7.2100079.
9
Omicron severity: milder but not mild.
Lancet. 2022 Jan 29;399(10323):412-413. doi: 10.1016/S0140-6736(22)00056-3. Epub 2022 Jan 19.
10
Effectiveness of infection prevention and control interventions, excluding personal protective equipment, to prevent nosocomial transmission of SARS-CoV-2: a systematic review and call for action.
Infect Prev Pract. 2022 Mar;4(1):100192. doi: 10.1016/j.infpip.2021.100192. Epub 2021 Nov 29.
本文引用的文献
1
Evidence mounts on the disproportionate effect of COVID-19 on ethnic minorities.
Lancet Respir Med. 2020 Jun;8(6):547-548. doi: 10.1016/S2213-2600(20)30228-9. Epub 2020 May 10.
2
Characteristics of asymptomatic patients with SARS-CoV-2 infection in Jinan, China.
Microbes Infect. 2020 May-Jun;22(4-5):212-217. doi: 10.1016/j.micinf.2020.04.011. Epub 2020 May 7.
3
Asymptomatic Transmission, the Achilles' Heel of Current Strategies to Control Covid-19.
N Engl J Med. 2020 May 28;382(22):2158-2160. doi: 10.1056/NEJMe2009758. Epub 2020 Apr 24.
4
Presymptomatic SARS-CoV-2 Infections and Transmission in a Skilled Nursing Facility.
N Engl J Med. 2020 May 28;382(22):2081-2090. doi: 10.1056/NEJMoa2008457. Epub 2020 Apr 24.
5
Hospitalization Rates and Characteristics of Patients Hospitalized with Laboratory-Confirmed Coronavirus Disease 2019 - COVID-NET, 14 States, March 1-30, 2020.
MMWR Morb Mortal Wkly Rep. 2020 Apr 17;69(15):458-464. doi: 10.15585/mmwr.mm6915e3.
6
Universal Screening for SARS-CoV-2 in Women Admitted for Delivery.
N Engl J Med. 2020 May 28;382(22):2163-2164. doi: 10.1056/NEJMc2009316. Epub 2020 Apr 13.
7
Epidemiological and Clinical Predictors of COVID-19.
Clin Infect Dis. 2020 Jul 28;71(15):786-792. doi: 10.1093/cid/ciaa322.
8
Covid-19: identifying and isolating asymptomatic people helped eliminate virus in Italian village.
BMJ. 2020 Mar 23;368:m1165. doi: 10.1136/bmj.m1165.
Zotero 插件